rs776290356
Positions:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBP7
The NM_001099402.2(CCNK):āc.1524A>Cā(p.Pro508=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.000063 ( 0 hom., cov: 6)
Exomes š: 0.000075 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
CCNK
NM_001099402.2 synonymous
NM_001099402.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.896
Genes affected
CCNK (HGNC:1596): (cyclin K) The protein encoded by this gene is a member of the transcription cyclin family. These cyclins may regulate transcription through their association with and activation of cyclin-dependent kinases (CDK) that phosphorylate the C-terminal domain (CTD) of the large subunit of RNA polymerase II. This gene product may play a dual role in regulating CDK and RNA polymerase II activities. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 14-99510563-A-C is Benign according to our data. Variant chr14-99510563-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 402507.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.896 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCNK | NM_001099402.2 | c.1524A>C | p.Pro508= | synonymous_variant | 11/11 | ENST00000389879.9 | NP_001092872.1 | |
CCDC85C | NM_001144995.2 | c.*4683T>G | 3_prime_UTR_variant | 6/6 | ENST00000380243.9 | NP_001138467.1 | ||
CCNK | XM_005268154.5 | c.1524A>C | p.Pro508= | synonymous_variant | 11/11 | XP_005268211.1 | ||
CCNK | XM_047431839.1 | c.1524A>C | p.Pro508= | synonymous_variant | 12/12 | XP_047287795.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCNK | ENST00000389879.9 | c.1524A>C | p.Pro508= | synonymous_variant | 11/11 | 5 | NM_001099402.2 | ENSP00000374529 | P1 | |
CCDC85C | ENST00000380243.9 | c.*4683T>G | 3_prime_UTR_variant | 6/6 | 5 | NM_001144995.2 | ENSP00000369592 | P1 | ||
CCNK | ENST00000555049.5 | c.1117+3416A>C | intron_variant | 1 | ENSP00000452307 | |||||
CCNK | ENST00000553865.1 | n.4676A>C | non_coding_transcript_exon_variant | 5/5 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 2AN: 31668Hom.: 0 Cov.: 6 FAILED QC
GnomAD3 genomes
AF:
AC:
2
AN:
31668
Hom.:
Cov.:
6
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000753 AC: 15AN: 199280Hom.: 0 Cov.: 2 AF XY: 0.0000634 AC XY: 7AN XY: 110442
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
15
AN:
199280
Hom.:
Cov.:
2
AF XY:
AC XY:
7
AN XY:
110442
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000632 AC: 2AN: 31668Hom.: 0 Cov.: 6 AF XY: 0.000136 AC XY: 2AN XY: 14684
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
2
AN:
31668
Hom.:
Cov.:
6
AF XY:
AC XY:
2
AN XY:
14684
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC data poor quality. Silent variant no splice impact - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at